

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.34358419 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.05070768 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.05070768 |
| 4 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.49821584 |
| 5 | formation of translation preinitiation complex (GO:0001731) | 4.43720636 |
| 6 | proteasome assembly (GO:0043248) | 4.40801403 |
| 7 | binding of sperm to zona pellucida (GO:0007339) | 4.39472155 |
| 8 | * negative regulation of ligase activity (GO:0051352) | 4.32042888 |
| 9 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.32042888 |
| 10 | sperm-egg recognition (GO:0035036) | 4.31952943 |
| 11 | regulation of mitochondrial translation (GO:0070129) | 4.31025815 |
| 12 | protein maturation by protein folding (GO:0022417) | 4.29056319 |
| 13 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.26832728 |
| 14 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.21578251 |
| 15 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.17891249 |
| 16 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.16697159 |
| 17 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.12407814 |
| 18 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.09707776 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.07315889 |
| 20 | viral transcription (GO:0019083) | 4.05962258 |
| 21 | translational termination (GO:0006415) | 4.01419058 |
| 22 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.01358729 |
| 23 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.01358729 |
| 24 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.99695967 |
| 25 | ribosomal small subunit biogenesis (GO:0042274) | 3.94868882 |
| 26 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.94729280 |
| 27 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.94729280 |
| 28 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.94729280 |
| 29 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.94132704 |
| 30 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.92791587 |
| 31 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.92791587 |
| 32 | ribosomal small subunit assembly (GO:0000028) | 3.92133928 |
| 33 | ribosomal large subunit biogenesis (GO:0042273) | 3.91577194 |
| 34 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.88740773 |
| 35 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.86031242 |
| 36 | cullin deneddylation (GO:0010388) | 3.84703515 |
| 37 | translational elongation (GO:0006414) | 3.82836862 |
| 38 | establishment of integrated proviral latency (GO:0075713) | 3.80774296 |
| 39 | cell-cell recognition (GO:0009988) | 3.75720122 |
| 40 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.73531568 |
| 41 | chaperone-mediated protein transport (GO:0072321) | 3.71830599 |
| 42 | chaperone-mediated protein complex assembly (GO:0051131) | 3.69433819 |
| 43 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.68781416 |
| 44 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.68781416 |
| 45 | mitotic metaphase plate congression (GO:0007080) | 3.65285909 |
| 46 | maturation of SSU-rRNA (GO:0030490) | 3.63411307 |
| 47 | translational initiation (GO:0006413) | 3.62867143 |
| 48 | DNA strand elongation (GO:0022616) | 3.62388000 |
| 49 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.60981326 |
| 50 | telomere maintenance via recombination (GO:0000722) | 3.60909021 |
| 51 | * positive regulation of ligase activity (GO:0051351) | 3.57971214 |
| 52 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.52348062 |
| 53 | DNA unwinding involved in DNA replication (GO:0006268) | 3.51936783 |
| 54 | mitotic sister chromatid segregation (GO:0000070) | 3.49270327 |
| 55 | protein deneddylation (GO:0000338) | 3.46801127 |
| 56 | DNA replication initiation (GO:0006270) | 3.45578533 |
| 57 | mitotic recombination (GO:0006312) | 3.45510256 |
| 58 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.45323106 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.43994061 |
| 60 | cellular protein complex disassembly (GO:0043624) | 3.42867861 |
| 61 | respiratory electron transport chain (GO:0022904) | 3.42256066 |
| 62 | spliceosomal snRNP assembly (GO:0000387) | 3.41840238 |
| 63 | mitotic chromosome condensation (GO:0007076) | 3.41642194 |
| 64 | * regulation of ligase activity (GO:0051340) | 3.40167548 |
| 65 | electron transport chain (GO:0022900) | 3.37401469 |
| 66 | cotranslational protein targeting to membrane (GO:0006613) | 3.36885417 |
| 67 | translation (GO:0006412) | 3.36406112 |
| 68 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.35455831 |
| 69 | nucleobase biosynthetic process (GO:0046112) | 3.35422995 |
| 70 | tricarboxylic acid cycle (GO:0006099) | 3.33086297 |
| 71 | protein targeting to ER (GO:0045047) | 3.32182912 |
| 72 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.31697764 |
| 73 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.29989257 |
| 74 | sperm motility (GO:0030317) | 3.29218179 |
| 75 | histone arginine methylation (GO:0034969) | 3.29107465 |
| 76 | protein neddylation (GO:0045116) | 3.26920997 |
| 77 | * positive regulation of cell cycle arrest (GO:0071158) | 3.26011658 |
| 78 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.23743331 |
| 79 | ribosome assembly (GO:0042255) | 3.23563577 |
| 80 | viral life cycle (GO:0019058) | 3.23308087 |
| 81 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.21715871 |
| 82 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.19523844 |
| 83 | DNA deamination (GO:0045006) | 3.19432393 |
| 84 | plasma membrane fusion (GO:0045026) | 3.19422223 |
| 85 | protein localization to endoplasmic reticulum (GO:0070972) | 3.19317109 |
| 86 | oxidative phosphorylation (GO:0006119) | 3.18988743 |
| 87 | purine nucleobase biosynthetic process (GO:0009113) | 3.17866213 |
| 88 | nuclear envelope reassembly (GO:0031468) | 3.17789160 |
| 89 | mitotic nuclear envelope reassembly (GO:0007084) | 3.17789160 |
| 90 | COPI coating of Golgi vesicle (GO:0048205) | 3.17785981 |
| 91 | Golgi transport vesicle coating (GO:0048200) | 3.17785981 |
| 92 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.17771623 |
| 93 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.15989072 |
| 94 | pseudouridine synthesis (GO:0001522) | 3.14827912 |
| 95 | ATP biosynthetic process (GO:0006754) | 3.14687765 |
| 96 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.14630197 |
| 97 | GTP biosynthetic process (GO:0006183) | 3.14428709 |
| 98 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.14053959 |
| 99 | establishment of viral latency (GO:0019043) | 3.14047783 |
| 100 | 7-methylguanosine mRNA capping (GO:0006370) | 3.13926600 |
| 101 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.13687973 |
| 102 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.13583351 |
| 103 | protein localization to mitochondrion (GO:0070585) | 3.13327403 |
| 104 | establishment of protein localization to mitochondrion (GO:0072655) | 3.13323721 |
| 105 | piRNA metabolic process (GO:0034587) | 3.13206946 |
| 106 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.12791692 |
| 107 | CENP-A containing nucleosome assembly (GO:0034080) | 3.12729624 |
| 108 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.12727116 |
| 109 | UTP biosynthetic process (GO:0006228) | 3.12292167 |
| 110 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.11403995 |
| 111 | telomere maintenance via telomere lengthening (GO:0010833) | 3.10611695 |
| 112 | ribosome biogenesis (GO:0042254) | 3.09173026 |
| 113 | inner mitochondrial membrane organization (GO:0007007) | 3.08417566 |
| 114 | chromatin remodeling at centromere (GO:0031055) | 3.07904303 |
| 115 | * regulation of cellular amine metabolic process (GO:0033238) | 3.07247266 |
| 116 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.06949340 |
| 117 | termination of RNA polymerase III transcription (GO:0006386) | 3.06949340 |
| 118 | rRNA modification (GO:0000154) | 3.06297995 |
| 119 | metaphase plate congression (GO:0051310) | 3.05259116 |
| 120 | protein complex disassembly (GO:0043241) | 3.05007678 |
| 121 | multicellular organism reproduction (GO:0032504) | 3.04528531 |
| 122 | RNA capping (GO:0036260) | 3.03467167 |
| 123 | 7-methylguanosine RNA capping (GO:0009452) | 3.03467167 |
| 124 | protein localization to chromosome, centromeric region (GO:0071459) | 3.02511302 |
| 125 | * cell cycle G1/S phase transition (GO:0044843) | 3.01555920 |
| 126 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.01555920 |
| 127 | de novo protein folding (GO:0006458) | 3.01508397 |
| 128 | acrosome assembly (GO:0001675) | 3.01254326 |
| 129 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.01140580 |
| 130 | protein localization to kinetochore (GO:0034501) | 2.99666534 |
| 131 | base-excision repair (GO:0006284) | 2.99570841 |
| 132 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.98668680 |
| 133 | sister chromatid segregation (GO:0000819) | 2.97954319 |
| 134 | protein targeting to mitochondrion (GO:0006626) | 2.97511924 |
| 135 | synaptonemal complex organization (GO:0070193) | 2.96798263 |
| 136 | viral mRNA export from host cell nucleus (GO:0046784) | 2.95889029 |
| 137 | tRNA aminoacylation for protein translation (GO:0006418) | 2.94769917 |
| 138 | * negative regulation of protein ubiquitination (GO:0031397) | 2.92875291 |
| 139 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.92771276 |
| 140 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.92584471 |
| 141 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.91913737 |
| 142 | de novo posttranslational protein folding (GO:0051084) | 2.91017543 |
| 143 | rRNA processing (GO:0006364) | 2.90681424 |
| 144 | DNA ligation (GO:0006266) | 2.88522320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.76980198 |
| 2 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 4.49764565 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.20536173 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.08671408 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.93391360 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.64871298 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.57781604 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.55479774 |
| 9 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.51310527 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.44231286 |
| 11 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.40897401 |
| 12 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.38607468 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.07742448 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.88296386 |
| 15 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.81462971 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.77984830 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.76688156 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.73864534 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.71363072 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.51539948 |
| 21 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.35341262 |
| 22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.30146876 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.29086032 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.27869418 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25474769 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.25339952 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.23603247 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.12831148 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12054927 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05490106 |
| 31 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.02136650 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.99381130 |
| 33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.97263416 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89277122 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.88589091 |
| 36 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84226803 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.76715990 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76238557 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.72948598 |
| 40 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64599520 |
| 41 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.62002733 |
| 42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61594756 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.59013415 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43076069 |
| 45 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42693587 |
| 46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40622024 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38929051 |
| 48 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35777758 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35143416 |
| 50 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31511111 |
| 51 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29298213 |
| 52 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.27627194 |
| 53 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27242467 |
| 54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25160271 |
| 55 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23692676 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23516688 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23170217 |
| 58 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22820215 |
| 59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21719801 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21490619 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21135112 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20412603 |
| 63 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18690965 |
| 64 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17258270 |
| 65 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13899098 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11252786 |
| 67 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.10075657 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09187098 |
| 69 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08350762 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07338027 |
| 71 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06859053 |
| 72 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06543169 |
| 73 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06517495 |
| 74 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04815892 |
| 75 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04677444 |
| 76 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.02312226 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00740715 |
| 78 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00063756 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99864814 |
| 80 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99708367 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99465327 |
| 82 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98603851 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96320108 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94999998 |
| 85 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93614484 |
| 86 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93579170 |
| 87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93362317 |
| 88 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91791474 |
| 89 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.91570034 |
| 90 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.90661578 |
| 91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90443413 |
| 92 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90007385 |
| 93 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89595698 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89256477 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88470377 |
| 96 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87833867 |
| 97 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.87585213 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85643694 |
| 99 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.85369996 |
| 100 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.84938830 |
| 101 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84453560 |
| 102 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.84063863 |
| 103 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.83620542 |
| 104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83473500 |
| 105 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.79101694 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78339606 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.73900862 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72863325 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71844570 |
| 110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.70955983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 5.54603068 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.29563883 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.67732482 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.38600764 |
| 5 | MP0010094_abnormal_chromosome_stability | 2.92667225 |
| 6 | MP0008932_abnormal_embryonic_tissue | 2.72839850 |
| 7 | MP0003077_abnormal_cell_cycle | 2.72678207 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.69456485 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.62062593 |
| 10 | MP0008058_abnormal_DNA_repair | 2.43833630 |
| 11 | MP0000749_muscle_degeneration | 2.39097291 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.37494454 |
| 13 | MP0006036_abnormal_mitochondrial_physio | 2.30035750 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.27376582 |
| 15 | * MP0001730_embryonic_growth_arrest | 2.22724810 |
| 16 | MP0008057_abnormal_DNA_replication | 2.20763147 |
| 17 | MP0003646_muscle_fatigue | 2.19709413 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.17799646 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.17397323 |
| 20 | MP0001929_abnormal_gametogenesis | 2.14976531 |
| 21 | MP0003698_abnormal_male_reproductive | 2.12680108 |
| 22 | MP0000751_myopathy | 2.10538125 |
| 23 | MP0010030_abnormal_orbit_morphology | 2.03233194 |
| 24 | MP0006035_abnormal_mitochondrial_morpho | 2.02914717 |
| 25 | MP0001529_abnormal_vocalization | 1.99857568 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.90360171 |
| 27 | MP0009697_abnormal_copulation | 1.74981946 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.72965454 |
| 29 | MP0002210_abnormal_sex_determination | 1.70538573 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.69035665 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.67314905 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.65287938 |
| 33 | MP0000747_muscle_weakness | 1.63620109 |
| 34 | MP0002269_muscular_atrophy | 1.61775998 |
| 35 | MP0003786_premature_aging | 1.60173086 |
| 36 | MP0008789_abnormal_olfactory_epithelium | 1.58116845 |
| 37 | MP0003186_abnormal_redox_activity | 1.56060447 |
| 38 | MP0000358_abnormal_cell_content/ | 1.53377706 |
| 39 | MP0001145_abnormal_male_reproductive | 1.52456271 |
| 40 | MP0005330_cardiomyopathy | 1.50288970 |
| 41 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45503950 |
| 42 | MP0005501_abnormal_skin_physiology | 1.41678702 |
| 43 | MP0003718_maternal_effect | 1.36912663 |
| 44 | MP0001697_abnormal_embryo_size | 1.29786439 |
| 45 | MP0002106_abnormal_muscle_physiology | 1.29768379 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.29366590 |
| 47 | * MP0002080_prenatal_lethality | 1.28058365 |
| 48 | MP0000350_abnormal_cell_proliferation | 1.27825626 |
| 49 | MP0004233_abnormal_muscle_weight | 1.26144341 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.26069064 |
| 51 | MP0002161_abnormal_fertility/fecundity | 1.25089294 |
| 52 | MP0002160_abnormal_reproductive_system | 1.24803299 |
| 53 | MP0000537_abnormal_urethra_morphology | 1.24327652 |
| 54 | MP0009672_abnormal_birth_weight | 1.24023915 |
| 55 | MP0004087_abnormal_muscle_fiber | 1.22983194 |
| 56 | MP0003941_abnormal_skin_development | 1.21862468 |
| 57 | * MP0001727_abnormal_embryo_implantation | 1.20373878 |
| 58 | MP0000653_abnormal_sex_gland | 1.18985253 |
| 59 | MP0005266_abnormal_metabolism | 1.16561517 |
| 60 | MP0003315_abnormal_perineum_morphology | 1.16175947 |
| 61 | MP0000490_abnormal_crypts_of | 1.14134517 |
| 62 | MP0000759_abnormal_skeletal_muscle | 1.11064381 |
| 63 | MP0005451_abnormal_body_composition | 1.11042166 |
| 64 | MP0000313_abnormal_cell_death | 1.10502489 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.08668623 |
| 66 | MP0005499_abnormal_olfactory_system | 1.08668623 |
| 67 | MP0005380_embryogenesis_phenotype | 1.07132841 |
| 68 | MP0001672_abnormal_embryogenesis/_devel | 1.07132841 |
| 69 | MP0003984_embryonic_growth_retardation | 1.06473801 |
| 70 | MP0001661_extended_life_span | 1.06329202 |
| 71 | MP0001243_abnormal_dermal_layer | 1.05564080 |
| 72 | MP0002088_abnormal_embryonic_growth/wei | 1.01970782 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.01769295 |
| 74 | MP0001905_abnormal_dopamine_level | 1.01528921 |
| 75 | MP0004147_increased_porphyrin_level | 1.01488666 |
| 76 | MP0005369_muscle_phenotype | 1.01229844 |
| 77 | MP0000372_irregular_coat_pigmentation | 1.00776298 |
| 78 | MP0002085_abnormal_embryonic_tissue | 1.00215240 |
| 79 | MP0001293_anophthalmia | 0.98555659 |
| 80 | MP0006292_abnormal_olfactory_placode | 0.98344701 |
| 81 | MP0003385_abnormal_body_wall | 0.95804198 |
| 82 | MP0009053_abnormal_anal_canal | 0.95275215 |
| 83 | MP0003011_delayed_dark_adaptation | 0.95255749 |
| 84 | MP0003329_amyloid_beta_deposits | 0.94831359 |
| 85 | MP0004272_abnormal_basement_membrane | 0.94415396 |
| 86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.94093290 |
| 87 | MP0003123_paternal_imprinting | 0.93961878 |
| 88 | MP0003705_abnormal_hypodermis_morpholog | 0.92845307 |
| 89 | MP0000762_abnormal_tongue_morphology | 0.91974514 |
| 90 | MP0002282_abnormal_trachea_morphology | 0.90932201 |
| 91 | MP0001881_abnormal_mammary_gland | 0.90697022 |
| 92 | MP0000579_abnormal_nail_morphology | 0.90636286 |
| 93 | MP0002060_abnormal_skin_morphology | 0.90129181 |
| 94 | MP0004197_abnormal_fetal_growth/weight/ | 0.89723691 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.89592577 |
| 96 | MP0005257_abnormal_intraocular_pressure | 0.88703559 |
| 97 | MP0009379_abnormal_foot_pigmentation | 0.87668589 |
| 98 | MP0008260_abnormal_autophagy | 0.87493217 |
| 99 | MP0002111_abnormal_tail_morphology | 0.85984096 |
| 100 | MP0004133_heterotaxia | 0.83838180 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.82101341 |
| 102 | MP0005384_cellular_phenotype | 0.81489952 |
| 103 | MP0002796_impaired_skin_barrier | 0.81316459 |
| 104 | MP0000049_abnormal_middle_ear | 0.80943099 |
| 105 | MP0002697_abnormal_eye_size | 0.80758786 |
| 106 | MP0001853_heart_inflammation | 0.80577320 |
| 107 | MP0002234_abnormal_pharynx_morphology | 0.78356751 |
| 108 | MP0005620_abnormal_muscle_contractility | 0.77137800 |
| 109 | MP0004134_abnormal_chest_morphology | 0.76215805 |
| 110 | MP0002084_abnormal_developmental_patter | 0.75964128 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.74464818 |
| 112 | MP0003942_abnormal_urinary_system | 0.71885005 |
| 113 | MP0001542_abnormal_bone_strength | 0.71791060 |
| 114 | MP0002938_white_spotting | 0.70703008 |
| 115 | MP0006054_spinal_hemorrhage | 0.70394880 |
| 116 | MP0001544_abnormal_cardiovascular_syste | 0.70276452 |
| 117 | MP0005385_cardiovascular_system_phenoty | 0.70276452 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.69986469 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.68726741 |
| 120 | MP0003937_abnormal_limbs/digits/tail_de | 0.68230952 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.67198518 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.67071939 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.66185949 |
| 124 | MP0000627_abnormal_mammary_gland | 0.66169216 |
| 125 | MP0002019_abnormal_tumor_incidence | 0.66057623 |
| 126 | MP0005023_abnormal_wound_healing | 0.65880407 |
| 127 | MP0005165_increased_susceptibility_to | 0.64771823 |
| 128 | MP0001915_intracranial_hemorrhage | 0.64745404 |
| 129 | MP0002086_abnormal_extraembryonic_tissu | 0.63986097 |
| 130 | MP0010630_abnormal_cardiac_muscle | 0.63904241 |
| 131 | MP0010307_abnormal_tumor_latency | 0.63374126 |
| 132 | MP0000920_abnormal_myelination | 0.62824413 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.62521837 |
| 134 | MP0002092_abnormal_eye_morphology | 0.61554872 |
| 135 | MP0010771_integument_phenotype | 0.61369617 |
| 136 | MP0001764_abnormal_homeostasis | 0.61104670 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.60921684 |
| 138 | MP0006138_congestive_heart_failure | 0.58209429 |
| 139 | MP0005389_reproductive_system_phenotype | 0.57572743 |
| 140 | MP0002972_abnormal_cardiac_muscle | 0.57041390 |
| 141 | MP0000733_abnormal_muscle_development | 0.56909568 |
| 142 | MP0001849_ear_inflammation | 0.56682605 |
| 143 | MP0003878_abnormal_ear_physiology | 0.55599669 |
| 144 | MP0005377_hearing/vestibular/ear_phenot | 0.55599669 |
| 145 | MP0009333_abnormal_splenocyte_physiolog | 0.54323335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolysis (HP:0004366) | 5.26246603 |
| 2 | Increased serum pyruvate (HP:0003542) | 5.26246603 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 4.89404052 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.59839999 |
| 5 | Cerebral hypomyelination (HP:0006808) | 4.27511107 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.23254174 |
| 7 | Mitochondrial inheritance (HP:0001427) | 4.10408541 |
| 8 | Acute encephalopathy (HP:0006846) | 4.03429592 |
| 9 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.89148527 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 3.77267377 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.77267377 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.75954757 |
| 13 | Increased CSF lactate (HP:0002490) | 3.75419487 |
| 14 | Progressive macrocephaly (HP:0004481) | 3.68075481 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 3.61597648 |
| 16 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.59378124 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.59378124 |
| 18 | Hepatic necrosis (HP:0002605) | 3.40177244 |
| 19 | Ragged-red muscle fibers (HP:0003200) | 3.40110434 |
| 20 | Leukodystrophy (HP:0002415) | 3.23161156 |
| 21 | Cerebral edema (HP:0002181) | 3.12980696 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.09546108 |
| 23 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.04706152 |
| 24 | Lipid accumulation in hepatocytes (HP:0006561) | 3.04271428 |
| 25 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.03966683 |
| 26 | Increased serum lactate (HP:0002151) | 3.03589450 |
| 27 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.00054201 |
| 28 | Exercise intolerance (HP:0003546) | 2.97459855 |
| 29 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.94340680 |
| 30 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.94340680 |
| 31 | Rhabdomyolysis (HP:0003201) | 2.94079757 |
| 32 | Respiratory failure (HP:0002878) | 2.87563958 |
| 33 | Selective tooth agenesis (HP:0001592) | 2.79805198 |
| 34 | Muscle fiber splitting (HP:0003555) | 2.79476610 |
| 35 | Lactic acidosis (HP:0003128) | 2.76794030 |
| 36 | Increased intramyocellular lipid droplets (HP:0012240) | 2.73402062 |
| 37 | CNS hypomyelination (HP:0003429) | 2.71002588 |
| 38 | Macrocytic anemia (HP:0001972) | 2.66238838 |
| 39 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.66093649 |
| 40 | Trismus (HP:0000211) | 2.65886832 |
| 41 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.65373663 |
| 42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.55977274 |
| 43 | Exercise-induced muscle cramps (HP:0003710) | 2.55743583 |
| 44 | Multiple enchondromatosis (HP:0005701) | 2.54365052 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.53903636 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.52255350 |
| 47 | Nemaline bodies (HP:0003798) | 2.50299061 |
| 48 | Breast hypoplasia (HP:0003187) | 2.49452445 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 2.48140529 |
| 50 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.47926626 |
| 51 | Birth length less than 3rd percentile (HP:0003561) | 2.47352037 |
| 52 | Amniotic constriction ring (HP:0009775) | 2.46282465 |
| 53 | Abnormality of placental membranes (HP:0011409) | 2.46282465 |
| 54 | Reticulocytopenia (HP:0001896) | 2.43316159 |
| 55 | 3-Methylglutaconic aciduria (HP:0003535) | 2.39063840 |
| 56 | Emotional lability (HP:0000712) | 2.38499380 |
| 57 | Respiratory difficulties (HP:0002880) | 2.36169519 |
| 58 | Chromsome breakage (HP:0040012) | 2.35688862 |
| 59 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.34656027 |
| 60 | Absent epiphyses (HP:0010577) | 2.34656027 |
| 61 | Chronic bronchitis (HP:0004469) | 2.34479226 |
| 62 | Insomnia (HP:0100785) | 2.34386306 |
| 63 | CNS demyelination (HP:0007305) | 2.29349234 |
| 64 | Optic disc pallor (HP:0000543) | 2.26969872 |
| 65 | Overriding aorta (HP:0002623) | 2.26683805 |
| 66 | Testicular atrophy (HP:0000029) | 2.24015039 |
| 67 | Rhinitis (HP:0012384) | 2.21941115 |
| 68 | Renal Fanconi syndrome (HP:0001994) | 2.21724011 |
| 69 | Myoglobinuria (HP:0002913) | 2.20481596 |
| 70 | Postnatal microcephaly (HP:0005484) | 2.18775893 |
| 71 | Premature rupture of membranes (HP:0001788) | 2.17886997 |
| 72 | Spastic diplegia (HP:0001264) | 2.17372538 |
| 73 | Pancytopenia (HP:0001876) | 2.17284047 |
| 74 | Delusions (HP:0000746) | 2.16780746 |
| 75 | Entropion (HP:0000621) | 2.14895302 |
| 76 | Difficulty climbing stairs (HP:0003551) | 2.14774475 |
| 77 | Sparse eyelashes (HP:0000653) | 2.13897468 |
| 78 | Abnormality of the anterior horn cell (HP:0006802) | 2.13655087 |
| 79 | Degeneration of anterior horn cells (HP:0002398) | 2.13655087 |
| 80 | Abnormality of the umbilical cord (HP:0010881) | 2.12262939 |
| 81 | Abnormal trabecular bone morphology (HP:0100671) | 2.08826377 |
| 82 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08694702 |
| 83 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08694702 |
| 84 | Abnormal protein glycosylation (HP:0012346) | 2.08694702 |
| 85 | Abnormal glycosylation (HP:0012345) | 2.08694702 |
| 86 | Calcaneovalgus deformity (HP:0001848) | 2.06318205 |
| 87 | Hyperacusis (HP:0010780) | 2.05267166 |
| 88 | Shoulder girdle muscle weakness (HP:0003547) | 2.03135806 |
| 89 | Aplastic anemia (HP:0001915) | 2.03098362 |
| 90 | Limb-girdle muscle atrophy (HP:0003797) | 2.00269058 |
| 91 | Carpal bone hypoplasia (HP:0001498) | 1.99826655 |
| 92 | Oral leukoplakia (HP:0002745) | 1.99811846 |
| 93 | Rough bone trabeculation (HP:0100670) | 1.94872186 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 1.94725741 |
| 95 | Cholecystitis (HP:0001082) | 1.94373368 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 1.94373368 |
| 97 | Hyporeflexia of lower limbs (HP:0002600) | 1.93299782 |
| 98 | Microvesicular hepatic steatosis (HP:0001414) | 1.93279854 |
| 99 | Vertebral compression fractures (HP:0002953) | 1.92358326 |
| 100 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.91817303 |
| 101 | Secondary amenorrhea (HP:0000869) | 1.91277901 |
| 102 | Pallor (HP:0000980) | 1.90891480 |
| 103 | Broad distal phalanx of finger (HP:0009836) | 1.90696293 |
| 104 | Hypokinesia (HP:0002375) | 1.89082897 |
| 105 | Deformed tarsal bones (HP:0008119) | 1.88811548 |
| 106 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.88033329 |
| 107 | Increased nuchal translucency (HP:0010880) | 1.87876115 |
| 108 | Neuroendocrine neoplasm (HP:0100634) | 1.87499681 |
| 109 | Opisthotonus (HP:0002179) | 1.86360816 |
| 110 | Abnormality of the preputium (HP:0100587) | 1.85635082 |
| 111 | Distal lower limb muscle weakness (HP:0009053) | 1.85121409 |
| 112 | Horseshoe kidney (HP:0000085) | 1.83737994 |
| 113 | Abnormal ciliary motility (HP:0012262) | 1.83407021 |
| 114 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83360905 |
| 115 | Abnormality of dentin (HP:0010299) | 1.83305054 |
| 116 | Gonadotropin excess (HP:0000837) | 1.83060431 |
| 117 | Meckel diverticulum (HP:0002245) | 1.82458010 |
| 118 | 11 pairs of ribs (HP:0000878) | 1.82418514 |
| 119 | Squamous cell carcinoma (HP:0002860) | 1.82130064 |
| 120 | Exertional dyspnea (HP:0002875) | 1.80575465 |
| 121 | Muscle stiffness (HP:0003552) | 1.80383870 |
| 122 | Palpitations (HP:0001962) | 1.79453132 |
| 123 | Nasal polyposis (HP:0100582) | 1.79232973 |
| 124 | Progressive muscle weakness (HP:0003323) | 1.78919257 |
| 125 | Personality changes (HP:0000751) | 1.77577591 |
| 126 | Achilles tendon contracture (HP:0001771) | 1.76181411 |
| 127 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75998716 |
| 128 | Cortical dysplasia (HP:0002539) | 1.75110706 |
| 129 | Exercise-induced myalgia (HP:0003738) | 1.73017614 |
| 130 | Lethargy (HP:0001254) | 1.72927170 |
| 131 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.72873571 |
| 132 | Calf muscle hypertrophy (HP:0008981) | 1.71845889 |
| 133 | Hypoplastic pelvis (HP:0008839) | 1.71373871 |
| 134 | Facial cleft (HP:0002006) | 1.70637286 |
| 135 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70194584 |
| 136 | Orthostatic hypotension (HP:0001278) | 1.69960589 |
| 137 | Autoamputation (HP:0001218) | 1.68606930 |
| 138 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.68357716 |
| 139 | Abnormality of the ileum (HP:0001549) | 1.68010109 |
| 140 | Proximal placement of thumb (HP:0009623) | 1.67262313 |
| 141 | Abnormality of reticulocytes (HP:0004312) | 1.67057054 |
| 142 | Fasciculations (HP:0002380) | 1.64947051 |
| 143 | Abnormal number of incisors (HP:0011064) | 1.64658800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.77756818 |
| 2 | VRK2 | 4.32150186 |
| 3 | PDK3 | 4.31935976 |
| 4 | PDK4 | 4.31935976 |
| 5 | WEE1 | 3.32063504 |
| 6 | EIF2AK1 | 3.19665753 |
| 7 | TESK1 | 3.18801737 |
| 8 | TESK2 | 3.17878974 |
| 9 | PASK | 3.15615604 |
| 10 | PDK2 | 2.62697180 |
| 11 | NME2 | 2.42005402 |
| 12 | NEK1 | 2.12437286 |
| 13 | PBK | 2.02902061 |
| 14 | TSSK6 | 1.98535830 |
| 15 | CDC7 | 1.95713853 |
| 16 | STK39 | 1.92656559 |
| 17 | LIMK1 | 1.88979951 |
| 18 | NME1 | 1.84623784 |
| 19 | PNCK | 1.80404418 |
| 20 | EIF2AK3 | 1.74051091 |
| 21 | STK16 | 1.73427982 |
| 22 | BCKDK | 1.67572294 |
| 23 | SMG1 | 1.50266631 |
| 24 | PAK4 | 1.49960596 |
| 25 | MYLK | 1.49680367 |
| 26 | IRAK3 | 1.39282824 |
| 27 | TTN | 1.38887577 |
| 28 | CCNB1 | 1.35747617 |
| 29 | NEK2 | 1.33531655 |
| 30 | RPS6KB2 | 1.32219518 |
| 31 | TTK | 1.25720860 |
| 32 | CDK8 | 1.25665209 |
| 33 | VRK1 | 1.19199575 |
| 34 | MST4 | 1.18140809 |
| 35 | PLK4 | 1.14250678 |
| 36 | TLK1 | 1.10709857 |
| 37 | ILK | 1.09341449 |
| 38 | PLK1 | 1.09302699 |
| 39 | PAK1 | 1.08883949 |
| 40 | OBSCN | 1.06896547 |
| 41 | KDR | 1.05200868 |
| 42 | AURKA | 1.04270814 |
| 43 | MAP2K7 | 1.03442285 |
| 44 | ICK | 1.01398070 |
| 45 | EPHA2 | 0.98337716 |
| 46 | WNK4 | 0.95556805 |
| 47 | PTK2B | 0.94133610 |
| 48 | AURKB | 0.91203657 |
| 49 | OXSR1 | 0.89184681 |
| 50 | SRPK1 | 0.89082714 |
| 51 | BCR | 0.88964684 |
| 52 | BRSK1 | 0.79282797 |
| 53 | MST1R | 0.79204814 |
| 54 | PIM2 | 0.78872000 |
| 55 | DYRK3 | 0.77903326 |
| 56 | SCYL2 | 0.77830249 |
| 57 | BRSK2 | 0.77509062 |
| 58 | TAF1 | 0.75429432 |
| 59 | PLK3 | 0.74839775 |
| 60 | MAP3K8 | 0.73863592 |
| 61 | ROCK2 | 0.73561936 |
| 62 | DAPK3 | 0.71323638 |
| 63 | CSNK1A1L | 0.71005003 |
| 64 | STK10 | 0.69835637 |
| 65 | CDK14 | 0.68026491 |
| 66 | LRRK2 | 0.67886498 |
| 67 | MAPKAPK3 | 0.67056472 |
| 68 | MAP3K11 | 0.66422500 |
| 69 | NTRK1 | 0.65768661 |
| 70 | ATR | 0.63247812 |
| 71 | ERBB4 | 0.62908470 |
| 72 | CHEK1 | 0.62462550 |
| 73 | MKNK1 | 0.62368528 |
| 74 | CSNK1G1 | 0.60928988 |
| 75 | CDK15 | 0.60928935 |
| 76 | CDK18 | 0.60898712 |
| 77 | TGFBR1 | 0.59874058 |
| 78 | CSNK2A2 | 0.57785401 |
| 79 | LATS2 | 0.55527805 |
| 80 | TRIM28 | 0.55427913 |
| 81 | CSNK2A1 | 0.55294654 |
| 82 | CDK11A | 0.55250402 |
| 83 | CSNK1G3 | 0.54234122 |
| 84 | CDK19 | 0.53810935 |
| 85 | CSNK1G2 | 0.53706862 |
| 86 | DYRK2 | 0.52275456 |
| 87 | RPS6KA5 | 0.51289524 |
| 88 | EPHB2 | 0.50940557 |
| 89 | MAPKAPK5 | 0.50011412 |
| 90 | ARAF | 0.48281398 |
| 91 | TAOK2 | 0.48227477 |
| 92 | PAK2 | 0.48142562 |
| 93 | ALK | 0.47138635 |
| 94 | ABL2 | 0.46296262 |
| 95 | EIF2AK2 | 0.45917236 |
| 96 | MET | 0.45513736 |
| 97 | CHEK2 | 0.45291204 |
| 98 | CLK1 | 0.44961263 |
| 99 | MUSK | 0.44242625 |
| 100 | ACVR1B | 0.44091636 |
| 101 | STK4 | 0.43803859 |
| 102 | ATM | 0.43254311 |
| 103 | CDK7 | 0.42979575 |
| 104 | BRAF | 0.42940831 |
| 105 | UHMK1 | 0.42158486 |
| 106 | PRKCI | 0.40595708 |
| 107 | PKN2 | 0.40346648 |
| 108 | PAK6 | 0.38725085 |
| 109 | LMTK2 | 0.37767674 |
| 110 | PTK2 | 0.33786082 |
| 111 | ZAK | 0.33709738 |
| 112 | TRIB3 | 0.33037629 |
| 113 | CDK4 | 0.29767770 |
| 114 | RPS6KA4 | 0.25538454 |
| 115 | GRK6 | 0.23020517 |
| 116 | CDK2 | 0.22144464 |
| 117 | CSNK1E | 0.21736949 |
| 118 | EEF2K | 0.20019816 |
| 119 | PLK2 | 0.19444595 |
| 120 | AKT2 | 0.18213308 |
| 121 | MAP3K12 | 0.18199691 |
| 122 | CDK1 | 0.17975439 |
| 123 | CAMK2G | 0.17755366 |
| 124 | DAPK1 | 0.17171403 |
| 125 | CAMK2D | 0.15839594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Proteasome_Homo sapiens_hsa03050 | 5.10680924 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.62594692 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.44770260 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.25409088 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.23610913 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.79461928 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.70043186 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.56177337 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.53150933 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.51008534 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.27772615 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.13902200 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.12690480 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.11524253 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.04001944 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.01902705 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.00751907 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.95001695 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85033535 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.82682440 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.82674773 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.73851689 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.72438074 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.68755244 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.66050759 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.61654930 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.61585887 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55660668 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51906083 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.49107822 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46929860 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43738305 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42950339 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36988247 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.34281480 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.23957402 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20204621 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16619320 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11807033 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11567219 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.07058649 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99494201 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 0.98720888 |
| 44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96807829 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94131973 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93413030 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87901466 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86742628 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84349557 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80885054 |
| 51 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78056166 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75039138 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74494836 |
| 54 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73368272 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71477062 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70773176 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68607144 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67781253 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66821443 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66517835 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63243535 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60370490 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59853452 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56818711 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55137690 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54801583 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54427106 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53169636 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52129268 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50989635 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50541355 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48016070 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42154011 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42107763 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.41506826 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41081354 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40594715 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35100020 |
| 79 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.34958867 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34945079 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32656965 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.31994341 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30554079 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30364570 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30066677 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28058901 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27948822 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.27944830 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25587827 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23053118 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.23034198 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.21185321 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20931056 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20051452 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19285381 |
| 96 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18534337 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.17870227 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.17618846 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.16367419 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16085634 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15636691 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.13252244 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.13138926 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.13075569 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.12335674 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12070138 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.11440645 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.10591117 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.09731446 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.09706340 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.09695036 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.07904774 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.07325292 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.07117661 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.06754320 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.06670192 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.05896155 |
| 118 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.05865513 |
| 119 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.04452313 |

